drugset / Trial / NCT01490580

Premedication Trial for Tracheal Intubation of the NEOnate

NCT01490580 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Multicenter double blind randomized controlled trial comparing "atropine+propofol" vs "atropine+atracurium+sufentanil" as a premedication prior to endotracheal intubation of the neonate. Primary outcome: pulse oxymetry value \< 80% for more than 60 seconds. Secondary outcomes: number of attempts, duration of the procedure, changes in physiologic parameters, short- and long-term neurodevelopmental outcome. Hypothesis: "atropine + propofol" compared to "atropine+atracurium+sufentanil" will significantly reduce the frequency of severe hypoxemia.

Timeline

Start
2012-05
Primary completion
2016-08
Completion
2020-04-15

Outcome

Missed primary endpoint

registry analysis (superiority test); Atropine Atracurium Sufentanil vs Atropine Propofol; p = 0.38; Risk Difference (RD) -6.4 (95% CI -21.0 to 8.1); Mixed Models Analysis NCT01490580 ↗

paper adjusted RD, -6.4; 95% CI, -21.0 to 8.1; P = .38 PMID 29715354 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atracurium Small molecule 0.3 mg/kg —
Subject Propofol Small molecule 1 mg/kg Other
Subject Propofol Small molecule 2.5 mg/kg Other
Comparator Sufentanil Other / unclassified 0.1 ug/kg —
Comparator Sufentanil Other / unclassified 0.2 ug/kg —
Background Atropine Other / unclassified 20 ug/kg —

Indications

No indication recorded.